Saturday 17 October 2026 Export ORGO’s income statement to Excel — free account

Organogenesis

ORGO Healthcare Drug Manufacturers Specialty & Generic

Organogenesis' revenue for fiscal 2025 (year ended December 2025) was $564.2 million, up 17.0% from fiscal 2024. In the quarter to June 2026, revenue fell 56.7%, EPS fell 670.0%, free cash flow grew 10.3% and total debt rose 10,940.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.99 0.12 −10.81%

Follow ORGO

Alert me

Market cap: $142.8M
P/E: 0.0×
Fwd P/E: −2.6×
Dividend yield: —
F-score: 4/9
Altman Z: 3.03
Beneish M: −1.41
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	57.56	0.00	+8 more quarters Free account
P/S ratio Full definition →	0.68	0.59	1.16	1.15
P/FCF ratio Full definition →	15.00	17.73	0.00	0.00
P/Operating CF Full definition →	(9.88)	14.34	16.65	173.90
P/B ratio Full definition →	2.11	1.24	2.19	2.10
Price to Tangible BV Full definition →	2.68	1.43	2.50	2.47
EV/Sales Full definition →	0.62	0.45	1.03	1.03
EV/EBITDA Full definition →	0.00	6.44	8.11	26.66
EV/Operating CF Full definition →	8.84	7.45	(56.35)	(12.35)
EV/FCF Full definition →	13.56	13.41	(23.75)	(9.28)
Quick Ratio Full definition →	2.59	2.75	3.11	2.58
Current Ratio Full definition →	3.52	3.53	3.62	3.32
Net Debt/EBITDA Full definition →	0.81	1.41	(1.16)	(2.25)
Debt/Assets Full definition →	2.66%	2.38%	2.14%	0.41%
Debt/Equity Full definition →	0.07	0.05	0.04	0.01
Asset Turnover Full definition →	1.05	1.04	1.03	0.97
Operating CF/Net income Full definition →	0.32	(0.38)	1.00	0.21
Capex/Depreciation Full definition →	(0.17)	(0.25)	(0.66)	(0.32)
Research and Development Expense of Revenue Full definition →	41.82%	40.72%	4.56%	8.76%
Selling, General and Administrative Expense of Revenue Full definition →	123.33%	175.10%	44.40%	52.86%
Intangible Assets out of Total Assets Full definition →	0.08	0.06	0.06	0.08
Share Based Compensation of Revenue Full definition →	6.98%	9.77%	1.92%	2.03%
Graham Net Nets Full definition →	(0.19)	(0.02)	0.10	0.08
Graham Number Full definition →	0.00	0.00	2.19	0.00
Earnings Yield Full definition →	(34.98%)	(7.59%)	1.74%	(2.61%)
Free Cash Flow Yield Full definition →	6.66%	5.64%	(3.73%)	(9.65%)
Revenue per Share Full definition →	0.34	0.29	1.78	1.19
Operating CF per Share Full definition →	(0.25)	0.17	0.31	0.02
Capex per Share Full definition →	(0.01)	(0.02)	(0.04)	(0.02)
Free Cash Flow per Share Full definition →	(0.25)	0.14	0.27	0.01
Cash per Share Full definition →	0.36	0.72	0.74	0.51
Shareholders Equity per Share Full definition →	1.15	1.91	2.37	2.01
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.15	1.91	2.37	2.01
Free Cash Flow Full definition →	(32.75)	17.98	34.77	0.84
Working Capital Full definition →	143.34	192.48	262.06	209.43
Capital Expenditures Full definition →	(1.10)	(3.15)	(4.65)	(2.23)
Net Current Asset Value Full definition →	(57.88)	(6.94)	63.59	45.05
EV/EBIT Full definition →	0.00	89.88	13.00	0.00
Capex to Sales Full definition →	0.03	0.08	0.02	0.01
Price to Operating Income Full definition →	0.00	118.82	14.69	0.00
Other line items
Average Receivables Full definition →	110.66	110.11	163.66	135.03
Average Payables Full definition →	29.51	26.64	30.43	32.10
Average Inventory Full definition →	31.16	28.88	27.92	33.31
Average Assets Full definition →	433.79	493.69	548.31	478.06
Average Common Equity Full definition →	190.76	243.73	281.51	266.84

Show all line items

Columns are period end dates

Stockrow Weekly